Author Archive

You are here: / Mireia Musquera, Lluis Peri, Tarek Ajami, Alberto Breda, Riccardo Campi,...
Mireia Musquera, Lluis Peri, Tarek Ajami, Alberto Breda, Riccardo Campi, Volkan Tugcu, Karel Decaestecker, Michael Stockle, Paolo Fornara, Nicolas Doumerc, Frances Vigues, Ravi Barod, Liesbeth Desender, Angelo Territo, Sergio Serni, GrazianoVignolini, Selçuk Sahin, Philipe Zeuschner, Neal Banga, Antonio Alcaraz

About Mireia Musquera, Lluis Peri, Tarek Ajami, Alberto Breda, Riccardo Campi, Volkan Tugcu, Karel Decaestecker, Michael Stockle, Paolo Fornara, Nicolas Doumerc, Frances Vigues, Ravi Barod, Liesbeth Desender, Angelo Territo, Sergio Serni, GrazianoVignolini, Selçuk Sahin, Philipe Zeuschner, Neal Banga, Antonio Alcaraz

This author has not written his bio yet.
But we are proud to say that Mireia Musquera, Lluis Peri, Tarek Ajami, Alberto Breda, Riccardo Campi, Volkan Tugcu, Karel Decaestecker, Michael Stockle, Paolo Fornara, Nicolas Doumerc, Frances Vigues, Ravi Barod, Liesbeth Desender, Angelo Territo, Sergio Serni, GrazianoVignolini, Selçuk Sahin, Philipe Zeuschner, Neal Banga, Antonio Alcaraz contributed 1479 entries already.
Edit the profile description here.

Entries by Mireia Musquera, Lluis Peri, Tarek Ajami, Alberto Breda, Riccardo Campi, Volkan Tugcu, Karel Decaestecker, Michael Stockle, Paolo Fornara, Nicolas Doumerc, Frances Vigues, Ravi Barod, Liesbeth Desender, Angelo Territo, Sergio Serni, GrazianoVignolini, Selçuk Sahin, Philipe Zeuschner, Neal Banga, Antonio Alcaraz

Robotic Assisted Kidney Transplantation: Update from the ERUS series

/by

Objectives To assess the safety and feasibility of early single‐dose mitomycin C (MMC) bladder instillation after robot‐assisted radical nephroureterectomy (RARNU) at a tertiary kidney cancer centre. RARNU with bladder cuff excision and subsequent MMC bladder instillation to reduce recurrence risk is the ‘gold standard’ for high‐risk upper urinary tract urothelial carcinoma (UUTUC). We adapted a […]

Elevated Pre‐operative C‐reactive Protein Is Associated with Renal Functional Decline and Non‐Cancer Mortality in Surgically Treated Renal Cell Carcinoma: Analysis from the INternational Marker Consortium for Renal Cancer [INMARC]

/by

Objectives To assess the safety and feasibility of early single‐dose mitomycin C (MMC) bladder instillation after robot‐assisted radical nephroureterectomy (RARNU) at a tertiary kidney cancer centre. RARNU with bladder cuff excision and subsequent MMC bladder instillation to reduce recurrence risk is the ‘gold standard’ for high‐risk upper urinary tract urothelial carcinoma (UUTUC). We adapted a […]

Combination Bacillus Calmette–Guérin and indoleamine 2,3‐dioxygenase 1 inhibitor therapy of murine orthotopic bladder cancer

/by

Objectives To assess the safety and feasibility of early single‐dose mitomycin C (MMC) bladder instillation after robot‐assisted radical nephroureterectomy (RARNU) at a tertiary kidney cancer centre. RARNU with bladder cuff excision and subsequent MMC bladder instillation to reduce recurrence risk is the ‘gold standard’ for high‐risk upper urinary tract urothelial carcinoma (UUTUC). We adapted a […]

The meaning of words – closing the gap in understanding between doctors and patients in 21st century consent

/by

Objectives To assess the safety and feasibility of early single‐dose mitomycin C (MMC) bladder instillation after robot‐assisted radical nephroureterectomy (RARNU) at a tertiary kidney cancer centre. RARNU with bladder cuff excision and subsequent MMC bladder instillation to reduce recurrence risk is the ‘gold standard’ for high‐risk upper urinary tract urothelial carcinoma (UUTUC). We adapted a […]

Functional outcomes after pyeloplasty in solitary kidneys: structured analysis with the implication of Acute Kidney Injury Network (AKIN) staging criteria to predict long‐term renal function recoverability

/by

Objectives To assess the safety and feasibility of early single‐dose mitomycin C (MMC) bladder instillation after robot‐assisted radical nephroureterectomy (RARNU) at a tertiary kidney cancer centre. RARNU with bladder cuff excision and subsequent MMC bladder instillation to reduce recurrence risk is the ‘gold standard’ for high‐risk upper urinary tract urothelial carcinoma (UUTUC). We adapted a […]

Effect of low‐energy shock wave therapy on intravesical epirubicin delivery in a rat model of bladder cancer

/by

Objectives To assess the safety and feasibility of early single‐dose mitomycin C (MMC) bladder instillation after robot‐assisted radical nephroureterectomy (RARNU) at a tertiary kidney cancer centre. RARNU with bladder cuff excision and subsequent MMC bladder instillation to reduce recurrence risk is the ‘gold standard’ for high‐risk upper urinary tract urothelial carcinoma (UUTUC). We adapted a […]

Ethnic and socio‐economic disparities in prostate cancer screening: lessons from New Zealand

/by

Objectives To assess the safety and feasibility of early single‐dose mitomycin C (MMC) bladder instillation after robot‐assisted radical nephroureterectomy (RARNU) at a tertiary kidney cancer centre. RARNU with bladder cuff excision and subsequent MMC bladder instillation to reduce recurrence risk is the ‘gold standard’ for high‐risk upper urinary tract urothelial carcinoma (UUTUC). We adapted a […]

A risk calculator predicting recurrence in lymph node metastatic penile cancer

/by

Objectives To assess the safety and feasibility of early single‐dose mitomycin C (MMC) bladder instillation after robot‐assisted radical nephroureterectomy (RARNU) at a tertiary kidney cancer centre. RARNU with bladder cuff excision and subsequent MMC bladder instillation to reduce recurrence risk is the ‘gold standard’ for high‐risk upper urinary tract urothelial carcinoma (UUTUC). We adapted a […]

Comparison of the Immunotherapy Response Evaluation Criteria in Solid Tumours (iRECIST) with RECIST for capturing treatment response of patients with metastatic urothelial carcinoma treated with pembrolizumab

/by

Objectives To assess the safety and feasibility of early single‐dose mitomycin C (MMC) bladder instillation after robot‐assisted radical nephroureterectomy (RARNU) at a tertiary kidney cancer centre. RARNU with bladder cuff excision and subsequent MMC bladder instillation to reduce recurrence risk is the ‘gold standard’ for high‐risk upper urinary tract urothelial carcinoma (UUTUC). We adapted a […]

© 2024 BJU International. All Rights Reserved.